Elon Musk’s proposed pay package in SpaceX’s IPO filing reveals what the company actually is: a $1 trillion monster built to colonize Mars

SpaceX’s IPO filing frames the company around a $7.5 trillion market cap target and a Mars-colonization mission, while Musk’s new 1 billion restricted-share package only vests if SpaceX reaches that valuation and builds a permanent Martian colony of at least 1 million people. The combined SpaceX-xAI-X entity reported a $4.3 billion net loss in Q1, driven largely by xAI’s $2.5 billion operating loss on $818 million of revenue and $7.7 billion of capex. The prospectus also points to a 2028 rollout of orbital AI compute and space-based data centers, implying heavy capital needs and a highly speculative investment case.

Analysis

This is less a pure SpaceX financing story than a capital-allocation wedge into the AI supply chain. If the combined vehicle can tap public markets to fund compute-heavy ambitions, the most immediate beneficiaries are infrastructure vendors rather than the equity itself: GPU demand stays locked in, but the financing risk shifts from venture balance sheets to public shareholders. NVDA remains the cleanest second-order winner because the market will underwrite multi-year compute buildouts even if end-user economics are unproven, effectively socializing the capex cycle while preserving supplier pricing power.

The market’s bigger blind spot is governance risk. A structure that ties equity economics to moonshot milestones creates incentive to overinvest in headline-grabbing capex and underweight near-term profitability, which can compress multiples if investors re-rate the business from “growth compounder” to “mission-controlled conglomerate.” That said, the near-term catalyst window is months, not years: IPO pricing, first-quarter post-merger disclosures, and any revision to 2028 deployment plans will drive sentiment long before Mars timelines matter.

The contrarian view is that the market may be over-discounting the absurdity and underpricing the optionality. If public capital absorbs part of the AI buildout, the company gains a cheaper cost of capital than private peers, which could allow it to outspend competing AI labs even while reporting ugly accounting losses. The main tail risk is not technical feasibility but investor fatigue: if capex remains elevated and revenue conversion lags into the next 2-3 quarters, the story can shift quickly from visionary to balance-sheet trap.

For NVDA, the setup is asymmetric but not unbounded: incremental demand from this type of customer is supportive, yet any evidence of GPU leasing distortions, related-party financing, or delayed monetization could trigger a multiple reset across high-duration AI names. The best trade is to own the picks-and-shovels while fading the narrative wrapper if IPO enthusiasm pushes the merged equity to a valuation that implies flawless execution over a decade.

Key Decisions for Investors

• Long NVDA into the IPO window (next 4-8 weeks): use any post-listing weakness as entry; thesis is that public-market funding extends the AI capex supercycle and supports utilization/pricing, with limited downside unless AI spend meaningfully decelerates.
• Pair trade: long NVDA / short a basket of high-duration, unprofitable AI application names over the next 1-3 months; if the market rewards infrastructure funding but punishes speculative cash burn, the spread should widen as capital rotates toward tangible compute demand.
• Initiate a short-dated put spread on the combined SpaceX vehicle into first filings/lockup-related headlines (2-4 months): attractive if the market prices Mars optionality before digesting governance and capex intensity; risk is a momentum squeeze if retail and crossover buyers chase the narrative.
• For event-driven accounts, buy downside protection on semicap equipment names if the IPO reveals aggressive internal GPU procurement terms; any sign of constrained supply or circular financing could force a multiple reset in the broader AI trade within 1-2 quarters.
• Avoid shorting NVDA outright on this headline alone; the better expression is short the story, not the supplier, because supplier economics remain levered to aggregate capex even if one customer’s business model looks increasingly speculative.